The consignment was delivered on Saturday, April 21, 2018 and this is the third product from Beximco Pharma in the world’s largest pharma market. They have successfully launched two products earlier Carvedilol in August 2016 and Sotalol in November 2017.
Beximco Pharma is a Bangladesh’s pharmaceutical company which begun to export their products to the US market. It has started exporting its third product Methocarbamol (500mg and 700mg) to the country now.
The consignment was delivered on Saturday, April 21, 2018 and this is the third product from Beximco Pharma in the world’s largest pharma market. They have successfully launched two products earlier Carvedilol in August 2016 and Sotalol in November 2017.
Methocarbamol is identical to muscle intoxicant drug Robaxin from Auxilium Pharmaceuticals. IQVIA market data says that the US market for Methocarbamol is of USD 23.37 million.
Beximco Pharma is the only Bangladeshi pharmaceutical company to export medicines to the US market ensuing the manufacturing site, which was first approved by the US Food and Drug Administration in June 2015.
